AzTrials
AzTrials

Autism Spectrum Disorder High-FunctioningPhase 1NCT06421272

APP-based Emotion Recognition Training Improve ASD Social Function

A Phase 1 study testing APP-based emotion recognition intervention and APP-based memory intervention in people with Autism Spectrum Disorder High-Functioning, run by University of Electronic Science and Technology of China at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The main aim of the study is to investigate whether APP-based emotional recognition training improve social function in autistic children. Read more about this study

Who is it for?
Ages 4 to 10 years
What is being tested?
APP-based emotion recognition intervention and APP-based memory intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteChina
Study dates
1 Jan 2023to 31 May 2024
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Inclusion criteria: Clinical diagnosis of Autism Spectrum Disorder and follow these criteria: (1) Age range: 4-10 years old, gender not limited;(2) Ethnicity: Han nationality;(3) Autism Diagnostic Observation Schedule-Second Edition (ADOS-2) Comparison Score greater than or equal to 5 points (Le et al., 2022);(4) Considering that only high-functioning autism individuals can successfully complete the eye-tracking tasks, children with a Wechsler score greater than or equal to 60 points are selected; Exclusion criteria: (1) No neurological complications, such as epilepsy, cerebral palsy, fragile X syndrome, etc.;(2) No prior medical interventions, such as taking antipsychotic drugs, receiving transcranial magnetic stimulation, acupuncture, etc.;(3) No abnormal imaging diagnosis or any brain injury.

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • University of Electronic Science and Technology

    Chengdu, Sichuan, 611731

    Weihua Zhao, Phd, +86 18780247797, zarazhao@uestc.edu.cn

    Recruiting

Other trials in China

About this study

The main aim of the study is to investigate whether APP-based emotional recognition training improve social function in autistic children.

Read the detailed description

50 ASD children age ranged from 4-10 years old will be randomly allocated to either app-based emotional recognition training or memory training groups for 2 months. Before and after training, some assessements were measured including Autism Diagnostic Observation Schedule-2, Childhood Autism Rating Scale, Wechsler Intelligence Scale and Psychoeducational Profile-3. Some other questionnaires are also collected including Social Responsibility Scale-2,Repetitive behavior scale-Revised,Caregiver Strains Questionnaire,Social Communication Questionnaire,Social Anxiety Scale for Children,Adaptive behavior assessment Schedule. Four eye-tracking tasks as follows: (1) Dynamic geometrical paired with dynamic child dancing; (2) Static neutral and emotional faces; (3) A dynamic gaze-following task; (4) social interaction behaviors paired with the toys alone; (5) spinning actions conducted via children paired with objects.

Being tested
APP-based emotion recognition intervention, APP-based memory intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • APP-based emotion recognition interventionBehavioural

    ASD children were asked to play emotion recognition-related games for eight weeks using iPAD. Two 15-minsute sessions each day was required.

  • APP-based memory interventionBehavioural

    ASD children were asked to play memory-related games for eight weeks using iPAD. Two 15-minsute sessions each day was required.

Study groups in NCT06421272
Study groupRoleWhat they receive
APP-based emotion recognition trainningExperimentalExperimental group: ASD children were asked to do emotion recognition for eight weeks using iPAD. Two 15-minsute sessions each day was required.
Receives: Behavioral: APP-based emotion recognition intervention
APP-based memory trainingActive comparatorControl group: ASD children were asked to do memory training (i.e. 1 back) for eight weeks using iPAD. Two 15-minsute sessions each day was required.
Receives: Behavioral: APP-based memory intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ADOS-2 assessment

    ADOS-2 assessment

    Measured: 1-2 hour

  2. SRS-2

    SRS-2

    Measured: half an hour

Secondary outcomes (1)
  1. Visual performance across five tasks based on eye-tracking

    Tasked based eye-tracking performance including fixation time, fixation counts

    Measured: half an hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2024
  2. Study start1 Jan 2023
  3. Primary completion31 May 2024 (estimated)
  4. Study completion31 May 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Experimental group (emotion recognition); control group (memory training)
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06421272
Sponsor's protocol ID
UESTC-neuSCAN-94
Status last verified
May 2024
First submitted
7 May 2024
Last updated
20 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing APP-based emotion recognition intervention and APP-based memory intervention in people with Autism Spectrum Disorder High-Functioning, run by University of Electronic Science and Technology of China at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

ADOS-2 assessment (time frame: 1-2 hour). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in